Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.

Abstract

Recombinant Factor VIIa use in MPH is safe, improves coagulopathy, was not effective in decreasing blood product transfusion requirements, and may contribute to an improved predicted mortality.